CCC
REGN icon

Chesapeake Capital Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

Chesapeake Capital Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
603
+7
+1% +$4.76K 0.2% 144
2026
Q1 		$460K Hold
596
– – 0.33% 117
2025
Q4 		$460K Buy
+596
New +$405K 0.39% 117

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Chesapeake Capital Corp's REGN Position: Q2 2026 in Review

Chesapeake Capital Corp increased its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2026, buying an estimated $4.76K and bringing the position to 603 shares worth $376K. The position accounts for 0.2% of the portfolio, ranked #144.

Chesapeake Capital Corp first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $460K in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Chesapeake Capital Corp held 603 shares of Regeneron Pharmaceuticals worth $376K as of Q2 2026.
  • Chesapeake Capital Corp bought 7 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.76K.
  • Regeneron Pharmaceuticals made up 0.2% of Chesapeake Capital Corp's portfolio in Q2 2026, its #144 holding.
  • Chesapeake Capital Corp first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Chesapeake Capital Corp's Regeneron Pharmaceuticals position peaked at $460K in Q1 2026.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.